Relay Therapeutics logo

Relay Therapeutics Share Price (NASDAQ: RLAY)

$3.56

0.02

(0.56%)

Last updated on

Check the interactive Relay Therapeutics Stock chart to analyse performance

Relay Therapeutics stock performance

as on August 28, 2025 at 11:37 pm IST

  • Today's Low:$3.51
    Today's High:$3.57

    Day's Volatility :1.54%

  • 52 Weeks Low:$1.78
    52 Weeks High:$10.72

    52 Weeks Volatility :83.44%

Relay Therapeutics Stock Returns

PeriodRelay Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
15.91%
4.2%
0.0%
6 Months
9.85%
-8.0%
0.0%
1 Year
-47.73%
-12.1%
0.0%
3 Years
-84.61%
7.6%
-6.9%

Relay Therapeutics Inc Key Stats

Check Relay Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.57
Open
$3.54
Today's High
$3.695
Today's Low
$3.57
Market Capitalization
$610.3M
Today's Volume
$563.1K
52 Week High
$10.72
52 Week Low
$1.775
Revenue TTM
$8.4M
EBITDA
$-335.9M
Earnings Per Share (EPS)
$-1.91
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-46.24%

Stock Returns calculator for Relay Therapeutics Stock including INR - Dollar returns

The Relay Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Relay Therapeutics investment value today

Current value as on today

₹56,808

Returns

₹43,192

(-43.19%)

Returns from Relay Therapeutics Stock

₹47,877 (-47.88%)

Dollar Returns*

₹4,685 (+4.68%)

Indian investors sentiment towards Relay Therapeutics Stock

-4%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Relay Therapeutics Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Relay Therapeutics Inc

  • Name

    Holdings %

  • SB INVESTMENT ADVISERS (UK) LTD

    16.25%

  • BlackRock Inc

    8.43%

  • Point72 Asset Management, L.P.

    7.83%

  • COMMODORE CAPITAL LP

    7.78%

  • Casdin Capital, LLC

    6.64%

  • Vanguard Group Inc

    5.46%

Analyst Recommendation on Relay Therapeutics Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Relay Therapeutics(by analysts ranked 0 to 5 stars)

Relay Therapeutics Share Price Target

What analysts predicted

Upside of 267.98%

Target:

$13.10

Current:

$3.56

Relay Therapeutics share price target is $13.10, a slight Upside of 267.98% compared to current price of $3.56 as per analysts' prediction.

Relay Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, RLAY stock has moved down by -85.5%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 10.00M → 677.0K (in $), with an average decrease of 57.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -77.06M → -70.37M (in $), with an average increase of 9.5% per quarter
  • RLAY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 109.5%
  • RLAY vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 200.8%
  • Price to Sales

    ForRLAY every $1 of sales, investors are willing to pay $68.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Relay Therapeutics Technicals Summary

Sell

Neutral

Buy

Relay Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Relay Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Relay Therapeutics Inc logo
-1.38%
9.85%
-47.73%
-84.61%
-91.12%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Relay Therapeutics Inc

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins; and RLY-1013, a degrader of estrogen receptor alpha. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Relay Therapeutics
Employees
197
CEO
Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Industry
Health Technology

Key Management of Relay Therapeutics Inc

NameTitle
Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
CEO, President & Director
Mr. Thomas Catinazzo
Chief Financial Officer
Mr. Brian R. Adams J.D.
Chief Legal Officer & Secretary
Mr. Peter Rahmer
Chief Corporate Development Officer
Dr. Donald A. Bergstrom M.D., Ph.D.
President of Research & Development
Ms. Dorothee Kern Ph.D.
Founder
Dr. David Elliot Shaw Ph.D.
Founder
Mr. Matthew P. Jacobson Ph.D.
Founder
Mr. Jim Watters Ph.D.
Chief Scientific Officer
Dr. Mahesh Padval Ph.D.
Chief Pharmaceutical Development Officer

Important FAQs about investing in RLAY Stock from India :

What is Relay Therapeutics share price today?

Relay Therapeutics share price today is $3.56 as on at the close of the market. Relay Therapeutics share today touched a day high of $3.57 and a low of $3.51.

What is the 52 week high and 52 week low for Relay Therapeutics share?

Relay Therapeutics share touched a 52 week high of $10.72 and a 52 week low of $1.78. Relay Therapeutics stock price today i.e. is closed at $3.56, lower by 66.79% versus the 52 week high.

How to invest in Relay Therapeutics Stock (RLAY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Relay Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Relay Therapeutics Shares that will get you 0.4213 shares as per Relay Therapeutics share price of $3.56 per share as on August 28, 2025 at 11:37 pm IST.

What is the minimum amount required to buy Relay Therapeutics Stock (RLAY) from India?

Indian investors can start investing in Relay Therapeutics (RLAY) shares with as little as ₹87.86 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Relay Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Relay Therapeutics share’s latest price of $3.56 as on August 28, 2025 at 11:37 pm IST, you will get 2.8090 shares of Relay Therapeutics. Learn more about fractional shares .

What are the returns that Relay Therapeutics has given to Indian investors in the last 5 years?

Relay Therapeutics stock has given -91.12% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?